The optimal timing of blood collection during the menstrual cycle for the assessment of endogenous sex hormones: Can interindividual differences in levels over the whole cycle be assessed on a single day?

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 1, 2002, Pages 147-151

  Unwin, Nigel ^a   Ahmad, Naseer ^a   Pollard, Tessa M ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b DURHAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTRADIOL; PROGESTERONE; SEX HORMONE;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CORRELATION ANALYSIS; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HUMAN EXPERIMENT; MENSTRUAL CYCLE; NORMAL HUMAN; PREMENOPAUSE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SAMPLING;

ADOLESCENT; ADULT; ANDROGENS; ESTRADIOL; FEMALE; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; PREMENOPAUSE; PROBABILITY; PROGESTERONE; PROSPECTIVE STUDIES; REFERENCE VALUES; TIME FACTORS;

EID: 0036165681     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Estrogens as a cause of human cancer: The Richard and Hilda Rosenthal Foundation Lecture
2. Endogenous hormones and breast cancer risk
3. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group
4. Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: Longitudinal results from the Massachusetts Women’s Health Study
5. The protective effects of estrogen on the cardiovascular system
6. A longitudinal study of the perimenopausal transition: Altered profiles of steroid and pituitary hormones, SHBG and bone mineral density
7. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52, 705 women with breast cancer and 108, 411 women without breast cancer
8. Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses’ Health Study (United States)
9. Energetic factors, ovarian steroids and the risk of breast cancer
10. Reproductive history and cardiovascular disease risk in postmenopausal women: A review of the literature
11. Abnormal estrogen conjugation in women at risk for familial breast cancer at the periovulatory stage of the menstrual cycle
12. Population variation in ovarian function
13. Diet, breast cancer, and sex hormone metabolism
14. Saliva as a medium for investigating intra- and interindividual differences in sex hormone levels in premenopausal women
15. Sex hormones in women in rural China and in Britain
16. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women
17. Breast cancer risk factors in two distinct ethnic groups: Indian and Pakistani versus American premenopausal women
18. Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period
19. Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period
20. Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer
21. Hormone measures in finger-prick blood spot samples: New field methods for reproductive endocrinology
22. Assessing estradiol in biobehavioral studies using saliva and blood spots: Simple radioimmunoassay protocols, reliability, and comparative validity